Table 1.
Case definitions for major infectious disease syndromes from clinic and household morbidity surveillance (HMS) in Asembo, western Kenya.
Figure 1.
Village randomization and number of children enrolled at the initial enrollment in December 2007 and during the ongoing enrollment during the study period from February 2008–March 2009. Children and person-time contribution given for the analysis of clinic-based surveillance and household morbidity surveillance – see methods. PBIDS = Population-based Infectious Disease Surveillance.
Table 2.
Baseline characteristics for participants in home zinc and comparison villages, western Kenya, February 2008–March 2009.
Table 3.
Effect of intervention on drug use and healthcare use for various disease syndromes during the intervention period from household morbidity surveillance (HMS), western Kenya, February 2008–March 2009.
Table 4.
Effect of home zinc on rate of sick visits to Lwak clinic, hospitalization, and mortality, western Kenya, from February 2008–March 2009, controlling for baseline rates of morbidity in home zinc and comparison villages.
Table 5.
Effect of home zinc on rate of sick visits to Lwak clinic, hospitalization, and mortality, western Kenya, from February 2008–March 2009, controlling for baseline rates of morbidity in home zinc and comparison villages.
Table 6.
Effect of home zinc on rates of reported morbidity at the household morbidity surveillance (HMS), western Kenya, from February 2008–March 2009, controlling for baseline rates of morbidity in home zinc and comparison villages.